Characteristic | Telephone LWSS2 (N = 37) | In-person LWSS2 (N = 35) | Control LWSS 2 (N = 28) | In-person LWSS 1 (N = 48) | Control LWSS 1 (N = 53) |
---|---|---|---|---|---|
NIHSS score, mean (SD, range) (Median, IQR) | 3.4 (3.4, 0–15) 2 (1–5) | 3.4 (3.6, 0–14) 2 (1–5) | 3.5 (3.8, 0–12) 2 (1–6) | 6.08 (4.4, 0–17) | 6.21 (5.05, 0–17) |
HRSD, mean (SD, range) | 18.0 (3.1, 12–26) | 19.1 (3.2, 14–27) | 18.3 (2.9, 13–23) | 20.0 (4.53, 10–29) | 19.8 (4.15, 11–29) |
Barthel index, mean (SD) (Median, IQR) | 91.8 (17.5) 98 (92–98) | 89.1 (20.3) 97 (89–97) | 88.0 (22.6) 97 (87–97) | 81.9 (23.2) | 83.5 (22.3 SD) |
Perceived percent recovery, mean (SD, range) | 61.6 (22.8, 0–95) | 60 (25.9, 2–95) | 65.9 (24.9, 10–95) | 46.3 (23.1, 0–90) | 55.3 (19.7, 10–100) |
History of depression (number, %) | 32 (86%) | 27 (77%) | 20 (71%) | 36 (75%) | 37 (69.8%) |
Currently taking antidepressant medication | 19 (51%) | 16 (46%) | 12 (43%) | 29 (60.4%) | 34 (64.2%) |
Ischemic stroke (includes ischemic with H conversion N, %) | 32 (86%) | 31 (89%) | 22 (79%) | 48 (100%) | 53 (100%) |
Intraparenchymal haemorrhagic stroke | 4 (11%) | 4 (11%) | 3 (11%) | 0 | 0 |
Subarachnoid haemorrhage | 1 (2%) | 0 | 3 (11%) | 0 | 0 |
Current antihypertensive medication | 26 (70%) | 28 (80%) | 20 (71%) | 39 (81.3%) | 40 (75%) |
Heart failure | 0 | 6 (17%) | 2 (7%) | 10.4% | 13.2% |
Diabetes | 11 (30%) | 12 (34%) | 5 (17%) | 16.7% | 43.4% |